A physician researcher, Dr. Robert Kushner, discusses the promising benefits of new GLP-1 RA antiobesity medications for patient health and body mass index. He emphasizes the growing interest from patients regarding these treatments. Additionally, the CMS reports a robust start to the 2025 marketplace open enrollment, continuing a trend of record-setting successes. A survey indicates that global medical costs are projected to rise by double digits for the third consecutive year, while patients who have insurance still experience medical debt or forgo care to avoid costs.
Mon, 25 Nov 2024 21:22:30 GMT | Medical Economics